Synoste Oy

About:

Synoste is a startup company developing novel, patient-friendly medical solutions for the treatment of skeletal deformities.

Website: http://synoste.com

Top Investors: HTGF | High-Tech Gruenderfonds, Lifeline Ventures, Evonik Venture Capital, Innovestor, EIT Digital Accelerator

Description:

Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient. Synoste utilizes smart materials and introduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life.

Total Funding Amount:

$11.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Espoo, Southern Finland, Finland

Founded Date:

2012-01-01

Contact Email:

contact(AT)synoste.com

Founders:

Antti Ritvanen, Harri Hallila, Juha Haaja

Number of Employees:

11-50

Last Funding Date:

2018-10-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai